These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 12073154

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
    Li M, Healy DR, Li Y, Simmons HA, Su M, Jee WS, Shen VW, Thompson DD.
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
    [Abstract] [Full Text] [Related]

  • 4. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M, Futaki N, Harada M, Kaku S.
    Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
    [Abstract] [Full Text] [Related]

  • 5. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
    Shiraishi A, Miyabe S, Nakano T, Umakoshi Y, Ito M, Mihara M.
    BMC Musculoskelet Disord; 2009 Jun 15; 10():66. PubMed ID: 19527501
    [Abstract] [Full Text] [Related]

  • 6. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen.
    Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, Ogata E.
    J Bone Miner Res; 2000 Apr 15; 15(4):770-9. PubMed ID: 10780869
    [Abstract] [Full Text] [Related]

  • 7. [Effects of alfacalcidol on osteoporosis in ovariectomized rats].
    Xia W, Meng X, Xing X.
    Zhonghua Yi Xue Za Zhi; 2000 Sep 15; 80(9):702-5. PubMed ID: 11798840
    [Abstract] [Full Text] [Related]

  • 8. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
    Shiraishi A, Ito M, Hayakawa N, Kubota N, Kubodera N, Ogata E.
    Calcif Tissue Int; 2006 Mar 15; 78(3):152-61. PubMed ID: 16525749
    [Abstract] [Full Text] [Related]

  • 9. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A, Tanaka M, Nozaki K, Mori M, Fukushima S, Mori H, Shiroya T, Nakamura T.
    Bone; 2013 Jul 15; 55(1):189-97. PubMed ID: 23486179
    [Abstract] [Full Text] [Related]

  • 10. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
    Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, Marumo K.
    Bone; 2010 Apr 15; 46(4):1170-9. PubMed ID: 20026440
    [Abstract] [Full Text] [Related]

  • 11. Tower climbing exercise started 3 months after ovariectomy recovers bone strength of the femur and lumbar vertebrae in aged osteopenic rats.
    Notomi T, Okimoto N, Okazaki Y, Nakamura T, Suzuki M.
    J Bone Miner Res; 2003 Jan 15; 18(1):140-9. PubMed ID: 12510816
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
    Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P.
    J Bone Miner Res; 1997 May 15; 12(5):820-31. PubMed ID: 9144349
    [Abstract] [Full Text] [Related]

  • 14. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
    Li CY, Jee WS, Chen JL, Mo A, Setterberg RB, Su M, Tian XY, Ling YF, Yao W.
    Calcif Tissue Int; 2003 Jan 15; 72(1):42-9. PubMed ID: 12370795
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
    Iwamoto J, Seki A, Takeda T, Yamada H, Sato Y, Yeh JK.
    J Nutr Sci Vitaminol (Tokyo); 2007 Jun 15; 53(3):191-7. PubMed ID: 17874822
    [Abstract] [Full Text] [Related]

  • 17. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.
    J Bone Miner Res; 2007 Jun 15; 22(6):849-59. PubMed ID: 17352644
    [Abstract] [Full Text] [Related]

  • 18. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ, Qi H, Crawford DT, Simmons HA, Xu G, Li M, Plum L, Clagett-Dame M, DeLuca HF, Thompson DD, Brown TA.
    J Bone Miner Res; 2005 Oct 15; 20(10):1742-55. PubMed ID: 16160732
    [Abstract] [Full Text] [Related]

  • 19. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
    Khajuria DK, Razdan R, Mahapatra DR.
    J Orthop Sci; 2014 Jul 15; 19(4):646-56. PubMed ID: 24668309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.